Literature DB >> 28120255

Treating Mental Health and Substance Use Disorders in Adolescents: What Is on the Menu?

Stanley Brewer1, Mark D Godley2, Leslie A Hulvershorn3.   

Abstract

Specific treatments targeting adolescents with substance use disorders (SUDs) have been developed over the last couple of decades. Despite these developmentally tailored treatments, long-term abstinence rates remain relatively low among adolescents receiving care. Research over the last decade has increasingly focused on adolescents with comorbid substance use and psychiatric disorders, in recognition of the barriers caused by inadequate treatment of co-occurring psychiatric disorders. Treatments targeting dually diagnosed youth are now regarded as essential to improving SUD treatment outcomes, but remain underutilized. A variety of treatment modalities such as behavioral therapy, family therapy, 12-step groups, motivational interviewing, contingency management, and combinations of these interventions have been modified for adolescents. In this article, we review the research on these treatments, as they apply to dually diagnosed youth. Furthermore, we explore the evidence for various treatments targeting comorbid SUD, specific to the presence of externalizing or internalizing disorders. The current evidence base supports the importance of integrated treatment targeting both SUD and psychiatric disorders simultaneously. High-quality treatment programs offering combinations of behavioral and family therapy, particularly with motivational interviewing and contingency management, are particularly well supported. In addition, we review various psychotropic medication treatments that have also been studied in conjunction with adolescent SUD treatment. Finally, we review research on post-treatment, supportive care that has been shown to improve long-term SUD outcomes. Recently conceptualized modular treatments, which offer personalized combinations of evidence-based treatments for specific disorders, have been proposed as a means of improving outcomes. Future research on modular programs must test the efficacy of individualized treatments when applied to combinations of psychiatric and SUDs in adolescents.

Entities:  

Keywords:  Adolescents; Dual diagnosis; Evidence-based treatments; Substance use disorders

Mesh:

Substances:

Year:  2017        PMID: 28120255     DOI: 10.1007/s11920-017-0755-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  89 in total

1.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

2.  Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment.

Authors:  Ya-Fen Chan; Michael L Dennis; Rodney R Funk
Journal:  J Subst Abuse Treat       Date:  2007-06-15

Review 3.  Evidence-based psychosocial treatments for adolescent substance abuse.

Authors:  Holly Barrett Waldron; Charles W Turner
Journal:  J Clin Child Adolesc Psychol       Date:  2008-01

Review 4.  Evidence for optimism: behavior therapies and motivational interviewing in adolescent substance abuse treatment.

Authors:  Mark J Macgowan; Bretton Engle
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-07

5.  Dual diagnosis and successful participation of adolescents in substance abuse treatment.

Authors:  B K Wise; S P Cuffe; T Fischer
Journal:  J Subst Abuse Treat       Date:  2001-10

6.  Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders.

Authors:  Ramon Solhkhah; Timothy E Wilens; Jeanine Daly; Jefferson B Prince; Stephanie L Van Patten; Joseph Biederman
Journal:  J Child Adolesc Psychopharmacol       Date:  2005-10       Impact factor: 2.576

Review 7.  Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review.

Authors:  Jack R Cornelius; Duncan B Clark; Oscar G Bukstein; Boris Birmaher; Ihsan M Salloum; Sandra A Brown
Journal:  Addict Behav       Date:  2005-08-15       Impact factor: 3.913

8.  A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.

Authors:  Paula D Riggs; Susan K Mikulich-Gilbertson; Robert D Davies; Michelle Lohman; Constance Klein; Shannon K Stover
Journal:  Arch Pediatr Adolesc Med       Date:  2007-11

9.  Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care.

Authors:  Stacy Sterling; Felicia Chi; Cynthia Campbell; Constance Weisner
Journal:  Alcohol Clin Exp Res       Date:  2009-04-30       Impact factor: 3.455

10.  Treating adolescents for substance abuse and comorbid psychiatric disorders.

Authors:  Paula D Riggs
Journal:  Sci Pract Perspect       Date:  2003-08
View more
  11 in total

1.  Expanding outcomes when considering the relative effectiveness of two evidence-based outpatient treatment programs for adolescents.

Authors:  Beth Ann Griffin; Lynsay Ayer; Joseph Pane; Brian Vegetabile; Lane Burgette; Daniel McCaffrey; Donna L Coffman; Matthew Cefalu; Rod Funk; Mark D Godley
Journal:  J Subst Abuse Treat       Date:  2020-07-06

Review 2.  Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders.

Authors:  Nora L Nock; Sonia Minnes; Jay L Alberts
Journal:  Birth Defects Res       Date:  2017-12-01       Impact factor: 2.344

3.  Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks, Offering a Public Health Perspective-A Commentary on Camenga et al.

Authors:  Rachel Gonzales-Castaneda; Larissa J Mooney; Richard A Rawson
Journal:  J Stud Alcohol Drugs       Date:  2019-07       Impact factor: 2.582

4.  Pharmacotherapy interventions for adolescent co-occurring substance use and mental health disorders: a systematic review.

Authors:  Kelli Scott; Sara J Becker; Sarah A Helseth; Ian J Saldanha; Ethan M Balk; Gaelen P Adam; Kristin J Konnyu; Dale W Steele
Journal:  Fam Pract       Date:  2022-03-24       Impact factor: 2.290

5.  Evidence Base on Outpatient Behavioral Treatments for Adolescent Substance Use, 2014-2017: Outcomes, Treatment Delivery, and Promising Horizons.

Authors:  Aaron Hogue; Craig E Henderson; Sara J Becker; Danica K Knight
Journal:  J Clin Child Adolesc Psychol       Date:  2018-06-12

Review 6.  Adolescent Substance Use Disorder Treatment: an Update on Evidence-Based Strategies.

Authors:  Matthew C Fadus; Lindsay M Squeglia; Emilio A Valadez; Rachel L Tomko; Brittany E Bryant; Kevin M Gray
Journal:  Curr Psychiatry Rep       Date:  2019-09-14       Impact factor: 5.285

7.  Randomized Controlled Trial of an Integrated Family-Based Treatment for Adolescents Presenting to Community Mental Health Centers.

Authors:  Ashli J Sheidow; Kristyn Zajac; Jason E Chapman; Michael R McCart; Tess K Drazdowski
Journal:  Community Ment Health J       Date:  2020-10-29

8.  Effects of anxiety sensitivity on cannabis, alcohol, and nicotine use among adolescents: evaluating pathways through anxiety, withdrawal symptoms, and coping motives.

Authors:  Ashley A Knapp; Nicholas P Allan; Renee Cloutier; Heidemarie Blumenthal; Shahrzad Moradi; Alan J Budney; Sarah E Lord
Journal:  J Behav Med       Date:  2020-09-27

9.  Evidence-Based Treatment of Young Adults With Substance Use Disorders.

Authors:  Scott E Hadland; Amy M Yule; Sharon J Levy; Eliza Hallett; Michael Silverstein; Sarah M Bagley
Journal:  Pediatrics       Date:  2021-01       Impact factor: 7.124

10.  Now and then: a ten-year comparison of young people in residential substance use disorder treatment receiving group dialectical behaviour therapy.

Authors:  Ely M Marceau; Gabriella Holmes; Jane Cutts; Lauren Mullaney; Denise Meuldijk; Michelle L Townsend; Brin F S Grenyer
Journal:  BMC Psychiatry       Date:  2021-07-20       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.